Vorasidenib

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, explains how clinicians may treat patients with gliomas of different grades.

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses recent advancements in the treatment of brain tumors.

In this video, Tracy T. Batchelor, MD, head of the department of neurology at Brigham and Women's Hospital, discusses the targeted therapies available or in development that target specific mutations in gliomas.

The FDA approved vorasidenib for certain patients with astrocytoma or oligodendroglioma.

Today is Glioblastoma Awareness Day.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses novel and experimental treatments for brain cancer.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses current challenges and opportunities in glioma treatment.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses current challenges and opportunities in glioma treatment.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses how diagnostic techniques for brain cancer are evolving.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses promising new brain cancer treatments.